GE HealthcareGEH200520solid tumorsGEH200521University Medical Center GroningenVanderbilt UniversityGE-269-004cancer therapy
…erapy. We present results from two phase 1 studies sponsored by GE Healthcare, GE-269-001 (NCT05629689) and GE-269-004 (NCT06398730).Methods …